News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
144,260 Results
Type
Article (6976)
Company Profile (10)
Press Release (137195)
Multimedia
Podcasts (21)
Webinars (6)
Section
Business (58960)
Career Advice (391)
Deals (10725)
Drug Delivery (27)
Drug Development (11850)
Employer Resources (32)
FDA (2097)
Job Trends (2517)
News (74552)
Policy (5597)
Tag
2027 Genetown Standard (2)
2027 Pharm Country Standard (2)
Academia (346)
Accelerated approval (13)
ADA (5)
Adcomms (3)
Allergies (25)
Alliances (7952)
ALS (39)
Alzheimer's disease (319)
Antibody-drug conjugate (ADC) (124)
Approvals (2172)
Artificial intelligence (162)
ASCO (47)
Autoimmune disease (77)
Automation (15)
Bankruptcy (135)
Belgium (8)
Best Places to Work (1928)
BIO (14)
Biologics (6)
BIOSECURE Act (2)
Biosimilars (66)
BioSpace Insights (20)
Biotechnology (22)
Bispecific (1)
Bladder cancer (21)
Brain cancer (13)
Breast cancer (176)
Cancer (1118)
Cardiovascular disease (66)
Career advice (361)
Career pathing (10)
CAR-T (57)
CDC (11)
CDMO (25)
Celiac Disease (2)
Cell therapy (177)
Cervical cancer (9)
Clinical research (10441)
Collaboration (449)
Commercialization (2)
Company closure (3)
Compensation (114)
Complete response letters (16)
COVID-19 (580)
CRISPR (16)
C-suite (701)
Cystic fibrosis (33)
Data (1402)
Denatured (5)
Depression (45)
Dermatology (15)
Diabetes (114)
Diagnostics (1394)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (11)
Drug discovery (85)
Drug pricing (27)
Drug shortages (5)
Duchenne muscular dystrophy (103)
Earnings (23459)
Editorial (22)
Employer branding (1)
Employer resources (32)
Events (16695)
Executive appointments (588)
FDA (2871)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (472)
Gene editing (38)
Generative AI (10)
Gene therapy (143)
GLP-1 (181)
Government (729)
Grass and pollen (1)
Guidances (102)
Healthcare (4144)
Hematology (25)
HIV (9)
Huntington's disease (13)
IgA nephropathy (22)
Immunology and inflammation (54)
Immuno-oncology (30)
Indications (35)
Infectious disease (650)
Inflammatory bowel disease (50)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (95)
Interviews (49)
IPO (4631)
IRA (8)
Job creations (606)
Job search strategy (301)
JPM (4)
Kidney cancer (9)
Kidney disease (9)
Labor market (16)
Layoffs (86)
Leadership (17)
Legal (1650)
Licensing (10)
Liver cancer (13)
Longevity (10)
Lung cancer (149)
Lymphoma (46)
Machine learning (17)
Management (9)
Manufacturing (228)
Marketing (3)
MASH (49)
Medical device (3137)
Medtech (3203)
Mergers & acquisitions (6664)
Metabolic disorders (274)
mRNA (36)
Multiple sclerosis (45)
NASH (3)
Netherlands (2)
Neurodegenerative disease (81)
Neuropsychiatric disorders (27)
Neuroscience (673)
NextGen: Class of 2026 (1182)
Non-profit (538)
Now hiring (6)
Obesity (109)
Opinion (89)
Ovarian cancer (39)
Pain (54)
Pancreatic cancer (56)
Parkinson's disease (67)
Partnered (13)
Patents (188)
Patient recruitment (151)
Patient selection (5)
Peanut (6)
People (20921)
Peptides (1)
Pharmaceutical (8)
Pharmacy benefit managers (6)
Phase 1 (3285)
Phase 2 (4960)
Phase 3 (3449)
Pipeline (2491)
Policy (62)
Postmarket research (228)
Preclinical (1250)
Press Release (18)
Prostate cancer (52)
Psychedelics (22)
Radiopharmaceuticals (104)
Rare diseases (259)
Real estate (812)
Recruiting (18)
Regenerative medicine (1)
Regulatory (4440)
Reports (35)
Research institute (377)
Resumes & cover letters (46)
Rett syndrome (5)
RNA editing (4)
RSV (8)
Schizophrenia (64)
Series A (96)
Series B (50)
Service/supplier (2)
Sickle cell disease (17)
Special edition (5)
Spinal muscular atrophy (23)
Sponsored (14)
Startups (742)
State (1)
Stomach cancer (1)
Substance use disorders (3)
Supply chain (27)
Tariffs (7)
The Weekly (16)
Vaccines (190)
Venture capital (35)
Weight loss (65)
Women's health (23)
Worklife (2)
Date
Today (38)
Last 7 days (156)
Last 30 days (592)
Last 365 days (6918)
2026 (5307)
2025 (6596)
2024 (7947)
2023 (8777)
2022 (11854)
2021 (12751)
2020 (11334)
2019 (8519)
2018 (6573)
2017 (6439)
2016 (5910)
2015 (6962)
2014 (5348)
2013 (4198)
2012 (4552)
2011 (4636)
2010 (4503)
Location
Africa (155)
Alabama (28)
Alaska (2)
Arizona (81)
Arkansas (5)
Asia (8938)
Australia (1166)
California (2768)
Canada (1826)
China (366)
Colorado (140)
Connecticut (131)
Delaware (121)
Europe (18999)
Florida (582)
Georgia (104)
Idaho (9)
Illinois (244)
India (24)
Indiana (186)
Iowa (3)
Japan (173)
Kansas (16)
Kentucky (8)
Louisiana (7)
Maine (9)
Maryland (376)
Massachusetts (1908)
Michigan (97)
Minnesota (185)
Missouri (16)
Montana (20)
Nebraska (10)
Nevada (32)
New Hampshire (28)
New Jersey (1008)
New Mexico (14)
New York (864)
North Carolina (449)
North Dakota (1)
Northern California (1398)
Ohio (89)
Oklahoma (8)
Oregon (4)
Pennsylvania (678)
Puerto Rico (17)
Rhode Island (9)
South America (225)
South Carolina (6)
Southern California (1116)
Tennessee (43)
Texas (651)
United States (10870)
Utah (66)
Vermont (1)
Virginia (49)
Washington D.C. (24)
Washington State (184)
West Virginia (1)
Wisconsin (64)
Wyoming (4)
144,260 Results for "redhawk holdings corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings
August 17, 2026
·
2 min read
Press Releases
COSCIENS ACQUIRES NUALTIS CORP.
September 10, 2026
·
19 min read
Press Releases
Protect Pharmaceutical Corp. Announces Closing of Environmental Infrastructure Acquisitions
August 18, 2026
·
5 min read
Press Releases
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
August 28, 2026
·
3 min read
FDA
REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five patients enrolled in REGENXBIO’s registrational trial. The biotech no longer plans to resubmit the candidate—which was rejected in February—in the near term.
August 24, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
Press Releases
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
September 24, 2026
·
3 min read
Press Releases
NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference
September 27, 2026
·
3 min read
Press Releases
Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options
August 25, 2026
·
5 min read
Press Releases
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
September 23, 2026
·
3 min read
1 of 14,426
Next
